{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T09:32:21Z","timestamp":1696411941242},"reference-count":16,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.3892\/ol.2012.712","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T06:04:29Z","timestamp":1336716269000},"page":"307-310","source":"Crossref","is-referenced-by-count":1,"title":["Multidisciplinary management of very advanced stage III and IV melanoma: Proof-of-principle"],"prefix":"10.3892","volume":"4","author":[{"given":"HAIM","family":"GUTMAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EYTAN","family":"BEN-AMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RONI","family":"SHAPIRA-FROMMER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JACOB","family":"SCHACHTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,5,11]]},"reference":[{"key":"key20180108092130_b1-ol-04-02-0307","unstructured":"National Cancer InstituteSEER Cancer Statistics Review, 1975\u20132006http:\/\/seer.cancer.gov\/csr\/1975_2006\/Accessed: April 12, 2012"},{"key":"key20180108092130_b2-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00008390-199812000-00010","article-title":"Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases","volume":"8","author":"Buzaid","year":"1998","journal-title":"Melanoma Res"},{"key":"key20180108092130_b3-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00000421-199902000-00015","article-title":"Sustained complete remission after chemobiohormonal therapy for metastatic melanoma","volume":"22","author":"Stein","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"key20180108092130_b4-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/cncr.10186","article-title":"A phase II study of neoadjuvant biochemotherapy for stage III melanoma","volume":"94","author":"Gibbs","year":"2002","journal-title":"Cancer"},{"key":"key20180108092130_b5-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00000637-199609000-00009","article-title":"Prolonged survival in patients with advanced melanoma treated with neoadjuvant chemotherapy followed by resection","volume":"37","author":"Sasson","year":"1996","journal-title":"Ann Plast Surg"},{"key":"key20180108092130_b6-ol-04-02-0307","first-page":"1533","article-title":"Concurrent chemobio- therapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon \u03b12b in patients with metastatic melanoma","volume":"20","author":"Bar","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180108092130_b7-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.soc.2005.12.002","article-title":"Management of metastatic melanoma 2005","volume":"15","author":"O\u2019Day","year":"2006","journal-title":"Surg Oncol Clin N Am"},{"key":"key20180108092130_b8-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/cncr.21909","article-title":"Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma","volume":"106","author":"Hwu","year":"2006","journal-title":"Cancer"},{"key":"key20180108092130_b9-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1200\/JCO.2005.04.5344","article-title":"Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma","volume":"24","author":"Lewis","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180108092130_b10-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1200\/JCO.2005.05.2498","article-title":"Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses","volume":"24","author":"Moschos","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180108092130_b11-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1200\/JCO.2007.15.7636","article-title":"Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma","volume":"27","author":"Hauschild","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180108092130_b12-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11912-007-0057-5","article-title":"Multidisciplinary management of special melanoma situations: oligometastatic disease and bulky nodal sites","volume":"9","author":"Sarnaik","year":"2007","journal-title":"Curr Oncol Rep"},{"key":"key20180108092130_b13-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1053\/ejso.2001.1158","article-title":"Induction chemotherapy: to downgrade aggressive cancers to improve curability by surgery and\/or radiotherapy","volume":"27","author":"Stephens","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"key20180108092130_b14-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00268-001-0027-2","article-title":"Surgery for abdominal metastases of cutaneous melanoma","volume":"25","author":"Gutman","year":"2001","journal-title":"World J Surg"},{"key":"key20180108092130_b15-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jso.20950","article-title":"Can surgeons improve survival in stage IV melanoma?","volume":"97","author":"Mosca","year":"2008","journal-title":"J Surg Oncol"},{"key":"key20180108092130_b16-ol-04-02-0307","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/cbr.1998.13.155","article-title":"A sequential four-drug chemotherapy and biotherapy with interferon alpha and GM-CSF - an innovative protocol for the treatment of metastatic melanoma","volume":"13","author":"Schachter","year":"1998","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2012.712\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T05:18:21Z","timestamp":1515388701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2012.712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,5,11]]},"published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.3892\/ol.2012.712"],"URL":"https:\/\/doi.org\/10.3892\/ol.2012.712","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]}}}